Health
UK Biobank suspends access following Alibaba revelations
Following recent revelations in The Guardian on breaches of UK Biobank data, the charity has suspended access to set in place a strict limit on the size of files that can be taken off the platform.
“We found that de-identified participant data made available to researchers at three academic institutions were listed for sale on a consumer website in China, owned by Alibaba," said CEO and Principal Investigator of UK Biobank, Professor Sir Rory Collins. "With support from both the UK and Chinese governments, Alibaba swiftly removed those listings before any sales were made. This is a clear breach of the contract signed by these academic institutions and they, along with the individuals involved, have had their access suspended.”
As a result of the data breach the UK Biobank has temporarily suspended all access, while they put in place a strict limit on the size of files that can be taken off the platform. In addition, the charity says that...

Share this article:
EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.
-
Libya5 days agoLibya’s fuel crisis offers lessons for energy security on both sides of the Mediterranean
-
Law5 days agoEU Cybersecurity Act could expose member states to costly investment treaty claims, legal opinion warns
-
Health4 days agoImpasse in European Union Tobacco Tax Reform: The Swedish veto
-
Kazakhstan2 days agoKazakhstan cuts water use by 874 mln m³ through new technologies
